Coagulation and splenectomy: An overview

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 317-324

  Cappellini, M D ^a,b   Grespi, E ^a,b   Cassinerio, E ^a,b   Bignamini, D ^a,b   Fiorelli, G ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Hypercoagulability; Phosphatidylserine; Splenectomy; Thalassemia; Thrombosis

Indexed keywords

BETA THALASSEMIA; BLOOD CLOTTING; BLOOD TRANSFUSION; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; ERYTHROCYTE; HUMAN; HYPERCOAGULABILITY; LUNG EMBOLISM; PORTAL VEIN THROMBOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPLENECTOMY; THALASSEMIA; THALASSEMIA MAJOR; VENOUS THROMBOEMBOLISM;

EID: 29744469968     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.039     Document Type: Conference Paper

References (38)

1. MODELL, C.B. 1977. Total management in thalassemia major. Arch. Dis. Child. 52: 489-496.
2. MODELL, C.B. & V.A. BERDOUKAS. 1984. The clinical approach to thalassemia. Grune & Stratton. New York.
3. HIRSH, J. & J.V. DACIE. 1966. Persistent post-splenectomy thrombocytosis and thrombo-embolism: a consequence of continuing anemia. Br. J. Haematol. 12: 44-53.
4. MOHREN, M., I. MARKMANN, U. DWORSCHAK, et al. 2004. Thromboembolic complications after splenectomy for hematologic diseases. Am. J. Hematol. 76: 143-146.
5. CHAFFANJON, P.C., P.Y. BRICHON, Y. RANCHOUP, et al. 1998. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging. World J. Surg. 22: 1082-1086.
6. LORING, L.A., D.M. PANICEK & M.S. KARPEH. 1998. Portal system thrombosis after splenectomy for neoplasm or chronic hematologic disorder: is routine surveillance imaging necessary? J. Comput. Assisted Tomogr. 22: 856-860.
7. VALERI, A., F. VENNERI, et al. 1998. Portal thrombosis: a rare complication of laparoscopic splenectomy. Surg. Endosc. 12: 1173-1176.
8. VAN'T RIET, M., J.W. BURGER, et al. 2000. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br. J. Surg. 87: 1229-1233.
9. TEFFERI, A., R.A. MESA et al. 2000. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 95: 2226-2233.
10. HASSN, A.M., M.A. AL-FALLOUJI, et al. 2000. Portal vein thrombosis following splenectomy. Br. J. Surg. 87: 362-373.
11. CAPPELLINI, M.D., L. ROBBIOLO, B.M. BOTTASSO, et al. 2000. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br. J. Haematol. 111: 467-473.
12. DELAITRE, B., G. CHAMPAULT, et al. 2000. Laparoscopic splenectomy for hematologic diseases: study of 275 cases. Ann. Chir. 125: 522-529.
13. AKPEK, G., D. MCANENY & L. WEINTRAUB. 2001. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases. J. Surg. Oncol. 77: 42-48.
14. WINSLOW, E.R., L.M. BRUNT, et al. 2002. Portal vein thrombosis after splenectomy. Am. J. Surg. 184: 631-635; discussion, pp. 635-636.
15. FUJITA, F., S. LYASS, et al. 2003. Portal vein thrombosis following splenectomy: identification of risk factors. Am. Surg. 69: 951-956.
16. IKEDA, M., M. SEKIMOTO, et al. 2005. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann. Surg. 241: 208-216.
17. RATTNER, D.W., L. ELLMAN & A.L. WARSHAW. 1993. Portal vein thrombosis after elective splenectomy: an underappreciated, potentially lethal syndrome. Arch. Surg. 128: 565-569.
18. SKARSGARD, E., J. DOSKI, et al. 1993. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. J. Pediatr. Surg. 28: 1109-1112.
19. HASSN, A.M., F.M. AL-FALLOUJI, T.I. OUF, et al. 2000. Portal vein thrombosis following splenectomy. Br. J. Surg. 87: 367-368.
20. ELDOR, A. & E.A. RACHMILEWITZ. 2002. The hypercoagulable state in thalassemia. Blood 99: 36-43.
21. SINNIAH, D., V. VEGNAENDRA & A. KAMMARUDDIN. 1977: Neurological complications of beta-thalassemia major. Arch. Dis. Child. 52: 977-980.
22. SUMIYOSHI, A., K. THAKERNGPOL & D. SONAKUL. 1992. Pulmonary microthromboemboli in thalassemia cases. Southeast Asian J. Trop. Med. Public Health 23: 29-31.
23. BORGNA-PIGNATTI, C., S. RUGOLOTTO & P. DE STEFANO. 2004. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89: 1187-1193.
24. TAHER, A., U. ISMA'EEL, G. MEIO, et al. 2005. The incidence of thromboembolic events among 8860 patients with thalassemia major and intermedia in the Mediterranean area and Iran. Presented at the Eighth Cooley's Anemia Symposium, March 17-19, 2005: A New York Academy of Sciences Symposium, in collaboration with Cooley's Anemia Foundation.
25. SINGER, S.T., D. FOOTE, E. VICHINSKY, et al. 2005. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Presented at the Eighth Cooley's Anemia Symposium, March 17-19, 2005: A New York Academy of Sciences Symposium, in collaboration with Cooley's Anemia Foundation.
26. BUTTHEP, P., A. BUNYARATVEJ, Y. FUNAHARA, et al. 1995. Alteration in vascular endothelial cell-related plasma proteins in thalassemic patients and their correlation with clinical symptoms. Thromb. Haemostasis 74: 1045-1049.
27. BUTTHEP, P., A. BUNYARATVEJ, Y. FUNAHARA, et al. 1997. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian J. Trop. Med. Public Health 28: 141A-148A.
28. WIENER, E., W. WANACHIWANAWIN, S. CHINPRASERTSUK, et al. 1996. Increased serum levels of macrophage colony-stimulating factor (M-CSF) in alpha- and beta-thalassemia syndromes: correlation with anaemia and monocytes activation. Eur. J. Haematol. 57: 364-369.
29. DEO, S.S., S.M. MERCHANT & A.C. KAPADIA. 1994. Elevated polymorphonuclear phagocytic function in thalassemia patients by chemiluminescence. Indian J. Pediatr. 61: 395-399.
30. GLADWIN, M.T., V. SACHDEV, M. JISON, et al. 2004. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 350: 886-895.
31. ELDOR, A., F. LELLOUCHE, A. GOLDFARB, et al. 1991. In vivo platelet activation in β-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 77: 1749-1753.
32. ELDOR, A., R. DURST, E. HY-AM, et al. 1999. A chronic hypercoagulable state in patients with β-thalassemia major is already present in childhood. Br. J. Haematol. 107: 739-746.
33. BORESTEIN-BEN YASHAR, V., Y. BARENHOLTZ, E. HY-AM, et al. 1993. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am. J. Hematol. 44: 63-67.
34. HELLEY, D., A. ELDOR, R. GIROT, et al. 1996. Comparison of the procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia. Thromb. Haemostasis 76: 322-327.
35. MANNU, F., P. ARESE, M.D. CAPPELLINI, et al. 1995. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes. Blood 86: 2014-2020.
36. CAPPELLINI, M.D., D. TAVAZZI, L. DUCA, et al. 1999. Metabolic indicators of oxidative stress correlate with haemochrome attachment to membrane, band-3 aggregation and erythrophagocytosis in beta-thalassemia intermedia. Bi. J. Haematol. 104: 504-510.
37. CONNOR, J., C.C. PAK, A.J. SCHROIT, et al. 1993. Exposure of phosphatidylserine in the outer leaflet of human red blood cells: relationship to cell density, cell age, and clearance by mononuclear cells. J. Biol. Chem. 269: 2399-2408.
38. NAITO, M., K. NAGASHIMA, T. MASCHIMA, et al. 1997. Phosphatidylserine externalization is downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. Blood 89: 2060-2066.